Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal moisture retention is a complex physiological process crucial for maintaining skin hydration and barrier function, rather than a specific molecular target or receptor. It involves a coordinated interplay of multiple molecular components and mechanisms within the epidermis. Key elements include Aquaporin 3 (AQP3) for water and glycerol transport in keratinocytes, Natural Moisturizing Factors (NMF) within corneocytes, endogenous glycerol, hyaluronic acid in the epidermis, the lipid barrier of the stratum corneum preventing transepidermal water loss (TEWL), and tight junction structures between the stratum granulosum and stratum corneum. Because it is a process, it is not considered a direct therapeutic target. For therapeutic intervention related to skin hydration, individual molecular components such as Aquaporin 3 would be more suitable targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal moisture retention.